Factors Associated with Using Opiates while under Extended-Release Naltrexone Blockade: A Descriptive Pilot Study

Extended-release naltrexone (XR-NTX) blocks the effects of opioids for 4 weeks, yet many patients continue to use them. To learn more about why this occurs, we collected self reports on subjective effects and drug use factors from participants’ most recent heroin/opiate use while under XR-NTX blockade.

Read more ›